147 related articles for article (PubMed ID: 3851697)
1. High concordance between marker profiles of 22 human leukemia-lymphoma cell lines tested with the same monoclonal antibodies before and during the second international workshop on human differentiation antigens.
Drexler HG; Gignac S; Misra B; Skowron L; Menon M; Minowada J
Cancer Immunol Immunother; 1985; 20(1):75-9. PubMed ID: 3851697
[TBL] [Abstract][Full Text] [Related]
2. Generation of a monoclonal anti-GP70 antibody and characterization of its reactivity with various human cell lines and cells from leukemia-lymphoma patients.
Gazitt Y; Sammar M; Treves AJ; Manny N; Gurfel D; Polliack A
Immunol Lett; 1986 Mar; 12(2-3):101-8. PubMed ID: 3522412
[TBL] [Abstract][Full Text] [Related]
3. Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies.
Sugimoto T; Tatsumi E; Kemshead JT; Helson L; Green AA; Minowada J
J Natl Cancer Inst; 1984 Jul; 73(1):51-7. PubMed ID: 6610792
[TBL] [Abstract][Full Text] [Related]
4. B-cell malignancies and differentiation antigens defined with monoclonal antibodies.
Kikuchi K; Koshiba H; Kasai K; Hiratsuka H; Fujimoto N; Uede T
Jpn J Clin Oncol; 1983 Sep; 13(3):517-31. PubMed ID: 6417375
[TBL] [Abstract][Full Text] [Related]
5. Expression of the BLA antigen, defined by the monoclonal 38.13 antibody, on Burkitt lymphoma lines, lymphoblastoid cell lines, their hybrids and other B-cell lymphomas and leukemias.
Klein G; Manneborg-Sandlund A; Ehlin-Henriksson B; Godal T; Wiels J; Tursz T
Int J Cancer; 1983 May; 31(5):535-42. PubMed ID: 6303966
[TBL] [Abstract][Full Text] [Related]
6. Marker profiles of human leukemia and lymphoma cell lines.
Minowada J; Koshiba H; Sagawa K; Kubonishi I; Lok MS; Tatsumi E; Han T; Srivastava BI; Ohnuma T
J Cancer Res Clin Oncol; 1981; 101(1):91-100. PubMed ID: 6974176
[TBL] [Abstract][Full Text] [Related]
7. Isoenzyme studies in human leukemia-lymphoma cells lines--II. Acid phosphatase.
Drexler HG; Gaedicke G; Minowada J
Leuk Res; 1985; 9(5):537-48. PubMed ID: 3874327
[TBL] [Abstract][Full Text] [Related]
8. Studies on the distribution of the antigens detected by some newly prepared monoclonal antibodies in normal hemopoietic and leukemic cells.
Babusíková O; Ujházy P; Hrivnáková A; Chorváth B; Poláková K
Neoplasma; 1985; 32(6):657-62. PubMed ID: 4088385
[TBL] [Abstract][Full Text] [Related]
9. Surface marker expression of human B-cell lymphomas.
Ishii Y; Kokai Y; Yamaguchi A; Tsubota H; Kikuchi K
AIDS Res; 1986 Dec; 2 Suppl 1():S87-93. PubMed ID: 3493786
[TBL] [Abstract][Full Text] [Related]
10. Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression.
Tedder TF; Clement LT; Cooper MD
J Immunol; 1985 May; 134(5):2983-8. PubMed ID: 3156922
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies (series Bra-) of broad (non-lineage) or restricted (myelomonocytic) reactivities elicited with granulocytes or K 562 cells.
Chorváth B; Sedlák J; Suliková M; Plesková I; Augustínová M; Duraj J
Neoplasma; 1989; 36(6):633-42. PubMed ID: 2615868
[TBL] [Abstract][Full Text] [Related]
12. Immunologic classification of leukemia and lymphoma.
Foon KA; Todd RF
Blood; 1986 Jul; 68(1):1-31. PubMed ID: 2941082
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of marker expression in B-cell leukemias and its diagnostic significance.
Menon M; Drexler HG; Minowada J
Leuk Res; 1986; 10(1):25-8. PubMed ID: 3080642
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the immunologic classification of leukemia.
Foon KA; Gale RP; Todd RF
Semin Hematol; 1986 Oct; 23(4):257-83. PubMed ID: 3095928
[TBL] [Abstract][Full Text] [Related]
15. [Reactivity of a novel monoclonal antibody ZCH-2B8a on normal hematopoietic cells and malignant cell lines and its significance].
Tang YM; Guo L; Yang SL; Shen HQ; Qian BQ; Zhang Y; Zhang HZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):990-4. PubMed ID: 17096904
[TBL] [Abstract][Full Text] [Related]
16. Analysis of human leukemia/lymphoma cell lines with monoclonal antibodies BA-1, BA-2 and BA-3.
LeBien T; Kersey J; Nakazawa S; Minato K; Minowada J
Leuk Res; 1982; 6(3):299-305. PubMed ID: 6956782
[TBL] [Abstract][Full Text] [Related]
17. Characterization of myeloid leukemia by monoclonal antibodies, with an emphasis on antibodies against myeloperoxidase.
van der Schoot CE; von dem Borne AE; Tetteroo PA
Acta Haematol; 1987; 78 Suppl 1():32-40. PubMed ID: 2829487
[TBL] [Abstract][Full Text] [Related]
18. Cell surface markers in leukemia: biological and clinical correlations.
Thiel E
Crit Rev Oncol Hematol; 1985; 2(3):209-60. PubMed ID: 3013441
[TBL] [Abstract][Full Text] [Related]
19. Distribution of antigens defined by OKB monoclonal antibodies on benign and malignant lymphoid cells and on nonlymphoid tissues.
Knowles DM; Tolidjian B; Marboe CC; Mittler RS; Talle MA; Goldstein G
Blood; 1984 Apr; 63(4):886-96. PubMed ID: 6423012
[TBL] [Abstract][Full Text] [Related]
20. Human monoclonal antibodies reactive with human myelomonocytic leukemia cells.
Posner MR; Santos DJ; Elboim HS; Tumber MB; Frackelton AR
Cancer Res; 1989 Apr; 49(7):1665-70. PubMed ID: 2924315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
